DNA methylation profiles in cancer diagnosis and therapeutics

Y Pan, G Liu, F Zhou, B Su, Y Li - Clinical and experimental medicine, 2018 - Springer
Cancer initiation and proliferation is regulated by both epigenetic and genetic events with
epigenetic modifications being increasingly identified as important targets for cancer …

[HTML][HTML] Epigenetic alterations in cancer

S Ilango, B Paital, P Jayachandran… - Frontiers in Bioscience …, 2020 - imrpress.com
Genetic and epigenetic modifications in DNA contribute to altered gene expression in aging
and cancer. In human cancers, epigenetic changes such as DNA methylation, histone …

Targeting ubiquitin specific proteases (USPs) in cancer immunotherapy: from basic research to preclinical application

H Gao, J Yin, C Ji, X Yu, J Xue, X Guan… - Journal of Experimental …, 2023 - Springer
Tumors have evolved in various mechanisms to evade the immune system, hindering the
antitumor immune response and facilitating tumor progression. Immunotherapy has become …

[HTML][HTML] Reprogramming of the tumor in the hypoxic niche: the emerging concept and associated therapeutic strategies

GZ Qiu, MZ Jin, JX Dai, W Sun, JH Feng… - Trends in pharmacological …, 2017 - cell.com
Hypoxia exerts a profound impact on diverse aspects of cancer biology. Increasing evidence
has revealed novel functions of hypoxia in cancer cell epigenomics, epitranscriptomics …

A biomimetic nanogenerator of reactive nitrogen species based on battlefield transfer strategy for enhanced immunotherapy

Q Feng, Y Li, N Wang, Y Hao, J Chang, Z Wang… - Small, 2020 - Wiley Online Library
Currently, cell membrane is always utilized for the construction of biomimetic nanoparticles.
By contrast, mimicking the intracellular activity seems more meaningful. Inspired by the …

Dynamic responses of the haematopoietic stem cell niche to diverse stresses

A Batsivari, MLR Haltalli, D Passaro, C Pospori… - Nature cell …, 2020 - nature.com
Adult haematopoietic stem cells (HSCs) mainly reside in the bone marrow, where stromal
and haematopoietic cells regulate their function. The steady state HSC niche has been …

A review of RRx-001: a late-stage multi-indication inhibitor of NLRP3 activation and chronic inflammation

N Jayabalan, B Oronsky, P Cabrales, T Reid, S Caroen… - Drugs, 2023 - Springer
Chronic unresolving inflammation is emerging as a key underlying pathological feature of
many if not most diseases ranging from autoimmune conditions to cardiometabolic and …

[HTML][HTML] Insights into DNMT1 and programmed cell death in diseases

L Yan, Q Geng, Z Cao, B Liu, L Li, P Lu, L Lin… - Biomedicine & …, 2023 - Elsevier
Abstract DNMT1 (DNA methyltransferase 1) is the predominant member of the DNMT family
and the most abundant DNMT in various cell types. It functions as a maintenance DNMT and …

USP7 cooperates with NOTCH1 to drive the oncogenic transcriptional program in T-cell leukemia

Q Jin, CA Martinez, KM Arcipowski, Y Zhu… - Clinical Cancer …, 2019 - AACR
Purpose: T-cell acute lymphoblastic leukemia (T-ALL) is an aggressive disease, affecting
children and adults. Chemotherapy treatments show high response rates but have …

Targeting the CD47-SIRPα innate immune checkpoint to potentiate antibody therapy in cancer by neutrophils

LM Behrens, TK van den Berg, M van Egmond - Cancers, 2022 - mdpi.com
Simple Summary Immunotherapy aims to engage various immune cells in the elimination of
cancer cells. Neutrophils are the most abundant leukocytes in the circulation and have …